Discover 1,858 paid clinical trials in Tennessee. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Whether you're a healthy volunteer interested in paid studies or someone looking for trials focused on specific conditions, Tennessee offers a wide variety of clinical research options. Leading facilities in Nashville, Memphis, and Knoxville are currently seeking participants, providing opportunities for individuals to access innovative treatments and specialized healthcare.
Filter
1
Filter results
Results: 1,858
FeaturedActive & Responsive
Type 2 Diabetes Studies on Blood Sugar and Weight Management for Adults Not on Insulin
for
Diabetes Mellitus, Type 2, Obesity
Location: New Bedford MA, East Greenwich RI, Bridgeport CT,
Sex: All
Age: 18 - 70+
Recruiting
FeaturedActive & Responsive
Investigational Oral GLP-1 Pill Studies for Adults With Type 2 Diabetes and an A1C Between 7% and 10.5%
for
Diabetes Mellitus, Type 2
Location: New Bedford MA, Bridgeport CT, Brooklyn NY,
Sex: All
Age: 18+
Recruiting
FeaturedActive & Responsive
Investigational Oral GLP-1 Pill Studies for Adults With Type 2 Diabetes Taking Only Metformin or No Diabetes Medicine
for
Diabetes Mellitus, Type 2
Location: Bridgeport CT, Brooklyn NY, Newport News VA, Bowie MD,
Sex: All
Age: 18+
Recruiting
Active & Responsive
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
for
Relapsed/Refractory Multiple Myeloma
Location: New York NY, Hackensack NJ, Richmond VA, Durham NC,
Sponsor: Caribou Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT05722418
Phase 1, Recruiting
Active & Responsive
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
for
Ulcerative Colitis
Location: London, Boston MA, Providence RI, Trois-Rivieres,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07186101
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Location: Boston MA, New York NY, Philadelphia PA, Baltimore MD,
Sponsor: Nuvalent Inc.
Sex: All
Age: 12+
Code: NCT05384626
Phase 1, Phase 2, Recruiting
Active & Responsive
Bioequivalence Study With Clinical Endpoint Comparing Bimatoprost Ophthalmic Solution 0.01% and LUMIGANĀ® in the Treatment of Chronic Open-Angle Glaucoma or Ocular Hypertension in Both Eyes.
for
Glaucoma, Open-Angle, Ocular Hypertension
Location: New Smyrna Beach FL, Morrow GA, Roswell GA,
Sponsor: Amneal Pharmaceuticals, LLC
Sex: All
Age: 18+
Code: NCT05401357
Phase 3, Recruiting
Active & Responsive
A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine
Phase 1 Study of a Self-amplifying RNA Vaccine (ITI-5000) in Stage 2-3 Triple Negative Breast Cancer
for
Triple Negative Breast Cancer (TNBC)
Location: Grand Rapids MI, Nashville TN, San Antonio TX,
Sponsor: Immunomic Therapeutics, Inc.
Sex: Female
Age: 18+
Code: NCT07652242
Phase 1, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Location: Brewer ME, Scarborough ME, Peabody MA, Boston MA,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07198074
Phase 3, Recruiting
Active & Responsive
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Topsham ME, Westbrook ME, Boston MA, Newton MA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07222800
Phase 3, Recruiting
Active & Responsive
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
for
Recurrent Head and Neck Squamous Cell Carcinoma,
Location: Boston MA, Waterford CT, New Haven CT, Stony Brook NY,